Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

London non-invasive emm1 collection 2022-2023

ABSTRACT: IGAS 2022-2023 upsurge - London non-invasive emm1 collection

PROVIDER: PRJEB71329 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR12373800_1.fastq.gz	Fastqsanger.gz
	ERR12373800_2.fastq.gz	Fastqsanger.gz
	ERR12373900_1.fastq.gz	Fastqsanger.gz
	ERR12373900_2.fastq.gz	Fastqsanger.gz
	ERR12373801_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 256

Similar Datasets

Streptococcus pyogenes emm1 causing invasive disease in Belgium (2020-2023)

Project description:Streptococcus pyogenes emm1 causing invasive disease in Belgium (2020-2023)

| PRJEB64886 | ENA

Streptococcus pyogenes strain:emm1

Project description:Streptococcus pyogenes emm1 causing invasive disease in Belgium (2020-2023)

| PRJNA1003449 | ENA

Influenza season 2022-2023 Oxford sequencing

Project description:Influenza season 2022-2023 Oxford sequencing

| PRJEB56915 | ENA

Planococcus citri strain:London, UK

Project description:Planococcus citri strain:London, UK Genome sequencing

| PRJNA196641 | ENA

Transcription start site profiling of a Streptococcus pyogenes emm1 strain

Project description:The human pathogen Streptococcus pyogenes, or group A streptococcus, is responsible for mild infections to life-threatening diseases. To determine the primary transcriptome of the emm1 strain S119, we have performed a differential RNA-Seq experiment based on selective Tobacco Acid Pyrophosphatase (TAP) treatment and 5' adapter ligation to differentiate primary transcripts (5' tri-phosphate) and processed RNAs (5' mono-phosphate). The libraries were performed on a mixture of RNAs prepared from bacteria cultured to late exponential phase in a rich growth culture medium supplemented or not with 15 mM of MgCl2

2018-11-30 | E-MTAB-7099 | biostudies-arrayexpress

Molecular Epidemiology of Invasive Group A Streptococcus Infections in Argentina during 2023

Project description:Molecular and epidemiological characteristics of iGAS isolates in Argentina

| PRJEB73573 | ENA

Salmonella enterica subsp. enterica serovar London

Project description:Salmonella enterica subsp. enterica serovar London Genome sequencing

| PRJNA931472 | ENA

Perspective on Schistosomiasis Drug Discovery: Highlights from a Schistosomiasis Drug Discovery Workshop at Wellcome Collection, London, September 2022.

Project description:In September 2022, the Drug Discovery Unit at the University of Dundee, UK, organised an international meeting at the Wellcome Collection in London to explore the current clinical situation and challenges associated with treating schistosomiasis. The aim of this meeting was to discuss the need for new treatments in view of the clinical situation and to ascertain what the key requirements would be for any potential new anti-schistosomals. This information will be essential to inform ongoing drug discovery efforts for schistosomiasis. We also discussed the potential drug discovery pathway and associated criteria for progressing compounds to the clinic. To date, praziquantel (PZQ) is the only drug available to treat all species causing schistosomiasis, but it is often unable to completely clear parasites from an infected patient, partially due to its inactivity against juvenile worms. PZQ-mediated mass drug administration campaigns conducted in endemic areas (e.g., sub-Saharan Africa, where schistosomiasis is primarily prevalent) have contributed to reducing the burden of disease but will not eliminate the disease as a public health problem. The potential for Schistosoma to develop resistance towards PZQ, as the sole treatment available, could become a concern. Consequently, new anthelmintic medications are urgently needed, and this Perspective aims to capture some of the learnings from our discussions on the key criteria for new treatments.

| S-EPMC10186373 | biostudies-literature

London Trauma Conference December 2022: Abstracts

Project description: Not available

| S-EPMC10594663 | biostudies-literature